Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Ibrutinib treatment ameliorates murine chronic graft-versus-host disease
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 124, Issue 11, Pages 4867-4876
Publisher
American Society for Clinical Investigation
Online
2014-10-01
DOI
10.1172/jci75328
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Selective Expression Rather than Specific Function of Txk and Itk Regulate Th1 and Th2 Responses
- (2014) N. Sahu et al. JOURNAL OF IMMUNOLOGY
- Failure-free survival after second-line systemic treatment of chronic graft-versus-host disease
- (2013) Y. Inamoto et al. BLOOD
- Bruton's tyrosine kinase (BTK) function is important to the development and expansion of chronic lymphocytic leukemia (CLL)
- (2013) J. A. Woyach et al. BLOOD
- Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
- (2013) J. A. Dubovsky et al. BLOOD
- Identification of Bruton's tyrosine kinase as a therapeutic target in acute myeloid leukemia
- (2013) S. A. Rushworth et al. BLOOD
- Fluctuations in pathogenic CD4+ T-cell subsets in a murine sclerodermatous model of chronic graft-versus-host disease
- (2013) Ji-Young Lim et al. IMMUNOLOGICAL INVESTIGATIONS
- Targeting BTK with Ibrutinib in Relapsed or Refractory Mantle-Cell Lymphoma
- (2013) Michael L. Wang et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targeting BTK with Ibrutinib in Relapsed Chronic Lymphocytic Leukemia
- (2013) John C. Byrd et al. NEW ENGLAND JOURNAL OF MEDICINE
- Low-Dose Interleukin-2 Therapy Restores Regulatory T Cell Homeostasis in Patients with Chronic Graft-Versus-Host Disease
- (2013) K.-i. Matsuoka et al. Science Translational Medicine
- Bortezomib-thalidomide-dexamethasone is superior to thalidomide-dexamethasone as consolidation therapy after autologous hematopoietic stem cell transplantation in patients with newly diagnosed multiple myeloma
- (2012) M. Cavo et al. BLOOD
- Tetraspanin CD37 Directly Mediates Transduction of Survival and Apoptotic Signals
- (2012) Rosa Lapalombella et al. CANCER CELL
- Extracorporeal photopheresis, a therapeutic option for cutaneous T-cell lymphoma and immunological diseases: state of the art
- (2012) Massimo Martino et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Lung Transplantation for Bronchiolitis Obliterans After Allogeneic Hematopoietic Stem Cell Transplantation
- (2012) Ursula M. Vogl et al. TRANSPLANTATION
- Donor B-cell alloantibody deposition and germinal center formation are required for the development of murine chronic GVHD and bronchiolitis obliterans
- (2011) M. Srinivasan et al. BLOOD
- Effector CD4+ T cells, the cytokines they generate, and GVHD: something old and something new
- (2011) J. M. Coghill et al. BLOOD
- Patient-reported quality of life is associated with severity of chronic graft-versus-host disease as measured by NIH criteria: report on baseline data from the Chronic GVHD Consortium
- (2011) J. Pidala et al. BLOOD
- Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765
- (2011) S. E. M. Herman et al. BLOOD
- Global and organ-specific chronic graft-versus-host disease severity according to the 2005 NIH Consensus Criteria
- (2011) S. Arai et al. BLOOD
- Treatment of chronic graft-versus-host disease in 2011
- (2011) Yoshihiro Inamoto et al. CURRENT OPINION IN HEMATOLOGY
- Tec family kinases Itk and Rlk / Txk in T lymphocytes: cross-regulation of cytokine production and T-cell fates
- (2011) Julio Gomez-Rodriguez et al. FEBS Journal
- Rituximab for prevention and treatment of graft-versus-host disease
- (2011) Mohamed A. Kharfan-Dabaja et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- Interleukin-2 and Regulatory T Cells in Graft-versus-Host Disease
- (2011) John Koreth et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Bruton tyrosine kinase inhibitor PCI-32765 ameliorates autoimmune arthritis by inhibition of multiple effector cells
- (2011) Betty Y Chang et al. ARTHRITIS RESEARCH & THERAPY
- Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease
- (2010) Daniel Wolff et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
- (2010) L. A. Honigberg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy of Rituximab in the Setting of Steroid-Refractory Chronic Graft-versus-Host Disease: A Systematic Review and Meta-Analysis
- (2009) Mohamed A. Kharfan-Dabaja et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Imatinib for refractory chronic graft-versus-host disease with fibrotic features
- (2009) A. Olivieri et al. BLOOD
- Altered B-cell homeostasis and excess BAFF in human chronic graft-versus-host disease
- (2009) S. Sarantopoulos et al. BLOOD
- Therapy with mycophenolate mofetil for refractory acute and chronic GVHD
- (2009) T Furlong et al. BONE MARROW TRANSPLANTATION
- Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
- (2009) Takanori Teshima et al. INTERNATIONAL JOURNAL OF HEMATOLOGY
- STAT3 Signaling in CD4+ T Cells Is Critical for the Pathogenesis of Chronic Sclerodermatous Graft-Versus-Host Disease in a Murine Model
- (2009) V. Radojcic et al. JOURNAL OF IMMUNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started